Whittier Trust’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,200
| Closed | -$2.68K | – | 1552 |
|
|
2024
Q2 | $2.68K | Sell |
2,200
-4,404
| -67% | -$5.37K | ﹤0.01% | 1406 |
|
|
2024
Q1 | $14.4K | Hold |
6,604
| – | – | ﹤0.01% | 1204 |
|
|
2023
Q4 | $10.2K | Hold |
6,604
| – | – | ﹤0.01% | 1233 |
|
|
2023
Q3 | $8.45K | Sell |
6,604
-1,759
| -21% | -$2.25K | ﹤0.01% | 1298 |
|
|
2023
Q2 | $14.4K | Hold |
8,363
| – | – | ﹤0.01% | 1193 |
|
|
2023
Q1 | $12.5K | Hold |
8,363
| – | – | ﹤0.01% | 1255 |
|
|
2022
Q4 | $13.3K | Hold |
8,363
| – | – | ﹤0.01% | 1236 |
|
|
2022
Q3 | $12K | Hold |
8,363
| – | – | ﹤0.01% | 1302 |
|
|
2022
Q2 | $15K | Sell |
8,363
-2,645
| -24% | -$4.74K | ﹤0.01% | 1240 |
|
|
2022
Q1 | $29K | Hold |
11,008
| – | – | ﹤0.01% | 1106 |
|
|
2021
Q4 | $48K | Hold |
11,008
| – | – | ﹤0.01% | 982 |
|
|
2021
Q3 | $56K | Hold |
11,008
| – | – | ﹤0.01% | 904 |
|
|
2021
Q2 | $70K | Hold |
11,008
| – | – | ﹤0.01% | 871 |
|
|
2021
Q1 | $85K | Hold |
11,008
| – | – | ﹤0.01% | 812 |
|
|
2020
Q4 | $72K | Hold |
11,008
| – | – | ﹤0.01% | 776 |
|
|
2020
Q3 | $73K | Hold |
11,008
| – | – | ﹤0.01% | 758 |
|
|
2020
Q2 | $92K | Hold |
11,008
| – | – | ﹤0.01% | 690 |
|
|
2020
Q1 | $84K | Hold |
11,008
| – | – | ﹤0.01% | 695 |
|
|
2019
Q4 | $91K | Hold |
11,008
| – | – | ﹤0.01% | 718 |
|
|
2019
Q3 | $81K | Hold |
11,008
| – | – | ﹤0.01% | 734 |
|
|
2019
Q2 | $124K | Hold |
11,008
| – | – | ﹤0.01% | 615 |
|
|
2019
Q1 | $118K | Hold |
11,008
| – | – | ﹤0.01% | 622 |
|
|
2018
Q4 | $166K | Hold |
11,008
| – | – | 0.01% | 541 |
|
|
2018
Q3 | $204K | Sell |
11,008
-2,205
| -17% | -$40.9K | 0.01% | 512 |
|
|
2018
Q2 | $302K | Hold |
13,213
| – | – | 0.01% | 439 |
|
|
2018
Q1 | $376K | Buy |
+13,213
| New | +$376K | 0.01% | 413 |
|